Copula-Based Model for Incorporating Single-Agent Historical Data into Dual-Agent Phase I Cancer Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Copula-Based Model for Incorporating Single-Agent Historical Data into Dual-Agent Phase I Cancer Trials

Published:2023-04-14 Issue:1 Volume:16 Page:71-88
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Hashizume Koichi¹²^ORCID,Tsuchida Jun³,Sozu Takashi⁴

Affiliation:

1. Department of Information and Computer Technology, Graduate School of Engineering, Tokyo University of Science, Tokyo, Japan

2. Global Biometrics and Data Science, Bristol Myers Squibb K.K., Tokyo, Japan

3. Department of Culture and Information Science, Faculty of Culture and Information Science, Doshisha University, Kyoto, Japan

4. Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan

Funder

JSPS KAKENHI

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2023.2190932

Reference31 articles.

1. A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors

2. Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors

3. The relationship between the power prior and hierarchical models

4. Dose Finding by the Continual Reassessment Method

5. Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges;Frontiers in Pharmacology;2023-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3